nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Artificial intelligence in peripheral blood films: an evolving landscape
|
Fan, Bingwen Eugene |
|
|
9 |
3 |
p. e174 |
artikel |
2 |
Artwork from trauma: the social life of medical data
|
Corby, Tom |
|
|
9 |
3 |
p. e175-e176 |
artikel |
3 |
Avatrombopag for chemotherapy-induced thrombocytopenia in patients with non-haematological malignancies: an international, randomised, double-blind, placebo-controlled, phase 3 trial
|
Al-Samkari, Hanny |
|
|
9 |
3 |
p. e179-e189 |
artikel |
4 |
Chronic lymphocytic leukaemia therapy: is less more?
|
Walter, Harriet S |
|
|
9 |
3 |
p. e169-e171 |
artikel |
5 |
Estimating the risk of child mortality attributable to sickle cell anaemia in sub-Saharan Africa: a retrospective, multicentre, case-control study
|
Ranque, Brigitte |
|
|
9 |
3 |
p. e208-e216 |
artikel |
6 |
Filling the data gaps on sickle cell anaemia in sub-Saharan Africa
|
Williams, Thomas Neil |
|
|
9 |
3 |
p. e172-e173 |
artikel |
7 |
Is acute myeloid leukaemia maintenance therapy necessary?
|
Ravandi, Farhad |
|
|
9 |
3 |
p. e177-e178 |
artikel |
8 |
Malignancy-associated haemophagocytic lymphohistiocytosis
|
Setiadi, Audi |
|
|
9 |
3 |
p. e217-e227 |
artikel |
9 |
Meeting the health needs of people from Afghanistan
|
The Lancet Haematology, |
|
|
9 |
3 |
p. e167 |
artikel |
10 |
Risk factors associated with venous and arterial neonatal thrombosis in the intensive care unit: a multicentre case-control study
|
Bhat, Rukhmi |
|
|
9 |
3 |
p. e200-e207 |
artikel |
11 |
Thrombopoietin receptor agonist in chemotherapy-induced thrombocytopenia
|
Lozano, Maria L |
|
|
9 |
3 |
p. e168-e169 |
artikel |
12 |
Transplantation for Fanconi anaemia: lessons learned from Brazil
|
Bonfim, Carmem |
|
|
9 |
3 |
p. e228-e236 |
artikel |
13 |
Understanding risk factors for neonatal thrombosis
|
Male, Christoph |
|
|
9 |
3 |
p. e171-e172 |
artikel |
14 |
Venetoclax consolidation after fixed-duration venetoclax plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (HOVON 139/GiVe): primary endpoint analysis of a multicentre, open-label, randomised, parallel-group, phase 2 trial
|
Kersting, Sabina |
|
|
9 |
3 |
p. e190-e199 |
artikel |